Sigma-Aldrich Corporation ‘s (SIAL) business unit – SAFC Commercial (“SAFC”) – and Applied Genetic Technologies Corp (NASDAQ:AGTC) have inked a deal, under which, SAFC will provide gene therapy manufacturing services to companies developing gene-based therapies. The companies did not disclose the financial terms of the deal. Applied Genetic Technologies Corp (NASDAQ:AGTC) weekly performance is -8.85%. On last trading day company shares ended up $28.21 Analysts mean target price for the company is $26.00. Applied Genetic Technologies Corp (NASDAQ:AGTC) distance from 50-day simple moving average is 59.57%.
Research analysts at RBC Capital began coverage on shares ofTransenterix (NASDAQ:TRXC) in a report released on Tuesday. The firm set an “outperform” rating and a $6.00 price target on the stock. RBC Capital’s price target would suggest a potential upside of 50.00% from the stock’s previous close. Transenterix Inc (NYSEMKT:TRXC) shares fell -10.65% in last trading session and ended the day on $5.12. TRXC its return on assets is -40.50%. Transenterix Inc (NYSEMKT:TRXC) quarterly performance is -51.70%.
Ophthotech Corp (NASDAQ:OPHT) major shareholder Lifesciences Ii L.P. Clarus sold 211,680 shares of Ophthotech Corp stock in a transaction that occurred on Wednesday, June 11th. The shares were sold at an average price of $45.42, for a total value of $9,614,505.60. Ophthotech Corp (NASDAQ:OPHT) shares moved down -5.04% in last trading session and was closed at $40.67, while trading in range of $40.52-$43.35. Ophthotech Corp (NASDAQ:OPHT) year to date performance is 25.72%.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) announced that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, and Francois Lebel, M.D., Senior Vice President, Clinical Development and Medical Operations will present at the 9th Annual JMP Securities Healthcare Conference on Wednesday, June 25th, 2014 at 10:00 a.m. ET at the Westin New York Grand Central in New York City. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) ended the last trading day at $4.05. Company weekly volatility is calculated as 4.90% and price to cash ratio as 6.75. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) showed a negative weekly performance of -7.11%.
Herman Miller, Inc. (NASDAQ:MLHR) reported fourth quarter adjusted EPS of $0.50 after the close Wednesday, compared to $0.43 in the previous year. The consensus estimate was for EPS of $0.46. First quarter EPS is expected to be between $0.44 and $0.48, compared to the consensus estimate of $0.48. Herman Miller, Inc. (NASDAQ:MLHR) net profit margin is 0.40% and weekly performance is -6.04%. On last trading day company shares ended up $29.71. Analysts mean target price for the company is $36.25. Herman Miller, Inc. (NASDAQ:MLHR) distance from 50-day simple moving average is -4.08%.